Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Total 13F shares
-
19,799,648
-
Share change
-
+535,808
-
Total reported value
-
$376,755,000
-
Price per share
-
$19.03
-
Number of holders
-
69
-
Value change
-
+$7,120,067
-
Number of buys
-
37
-
Number of sells
-
34
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q1 2016
As of 31 Mar 2016 Atara Biotherapeutics, Inc. - Common Stock (ATRA) had 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,799,648 shares of stock of the company.
Largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, UBS ASSET MANAGEMENT AMERICAS INC, EAGLE ASSET MANAGEMENT INC, Arrowpoint Asset Management, LLC, BlackRock Fund Advisors, BRIDGER MANAGEMENT, LLC, Visium Asset Management, LP, and VANGUARD GROUP INC.
This table shows 69 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.